Constructive Emotional Management Interventions

June 16, 2023 updated by: Rasha salah elsayed eweida, Alexandria University

Effect of Constructive Emotional Management Interventions on Emotional Regulation Difficulties and Peace of Mind Among Older Adults: Current Gap and Future Orientation

Emotional dysregulation is considered a phenotypic finding that has a purported impact on older adults' peace of mind. In this venue, employing constructive emotional management intervention is one of the breakthroughs that has been empirically targeted to restore positive emotional states and strengthen mental clarity in the geriatric population. Aim: to determine the effect of constructive emotional management interventions on emotional regulation difficulties and peace of mind among older adults. Design: The present study adopted a quasi-experimental methodological approach.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Most elderly people are emotionally stable and well-regulated up until the age of 70 to 80. Due to the effects of changes in their personal circumstances, some older people, however, regard their mental and physical deterioration as becoming self-evident before they turn 70. In old age, it's normal to experience things like forced retirement, the death of a spouse, changes in the home, or financial insecurity. In old age, a great variety of emotions are felt (Kunzmann et al., 2022).

Emotion is a psychological and cultural adaptation process that enables each person to respond adaptably and dynamically to environmental changes. Emotions add meaning to life, deepen human connections, teach people about their needs and feelings, and inspire them to take action (Troy et al., 2018). The phenomenon of emotions is complex. A single emotion consists of a cognitive evaluation, a bodily sensation, an intention, a personal sentiment, a motor response, and, frequently, an interpersonal component (Rompilla et al., 2022). Everyone, especially older adults, experience emotions on a regular basis. They face a wide range of emotions throughout any given day, along with their highs and lows. While some of these are manageable, others are more intense and challenging. It's common to experience those emotions occasionally. Yet, if they struggle with emotion management for an extended length of time, it may result in mental health issues and emotional regulation difficulties (McRae & Gross 2020).

A response to emotions that is poorly controlled and does not fall within the parameters of an acceptable emotional reaction is referred to as having problems with emotional regulation. The terms marked mood fluctuation, mood swings, and labile mood are also used to describe emotional regulation difficulties. Anger outbursts, anxiety, sadness, substance misuse, suicidal ideation, self-harm, and other self-destructive behaviors may be displayed by older adults who have trouble controlling their emotions. Negative moods, personality disorders, psychosis, and post- traumatic stress disorder are all strongly predicted by problems with emotional regulation. Over time, this disorder may affect older persons' quality of life, social contacts, and personal relationships (Dunn et al., 2018).

One's life balance can be thrown off by negative emotions, which are harmful. Lower mental health and inner peace are associated with higher levels of internal conflict, violence, and negative feelings and ideas. In fact, negative emotions and thoughts play a significant influence in the peace of mind maladjustment. In later life, especially, there may be a considerable correlation between peace of mind and effective emotion control. The spiritual and wisdom frequently represent a sense of inner harmony and a sense of wholeness and integration of the mind and body. The more inner peace elderly people have, the better off their minds are. As a result, regulating emotions may be a key therapy goal in psychological interventions for older persons (Isaacowitz 2022).

A reduction in the ability to control older adults' emotions might happen suddenly, but it can also happen gradually, slowly, and subtly. Hence, gerontological nurses should evaluate and identify any potential mental and emotional distress related to this crucial transitional aging era. Anxiety, despair, worry, and fear are frequently present throughout this time. Also, gerontological nurses should intervene to teach elders how to effectively control and manage their emotions and build personalized plans for each elder. Also, they should take action to stop older persons from making self- destructive decisions and engaging in behaviors like loneliness, sadness, suicide, denial of treatment, and denial of care from family members or medical professionals (Erhan et al.,2021).

Older persons who participate in educational emotional management nursing programs may experience an increase in positive emotions and a decrease in negative ones. The recommended therapies for the current study, constructive emotional management interventions, were constructed on the Dialectical Behavioral Therapy model (DBT). Linehan (2015) developed DBT, a cognitive behavioral treatment that incorporates evidence-based psychotherapy. Borderline personality disorder was its original intended application (BPD). Nowadays, it is utilized to treat a variety of emotional dysregulation and impulse control disorders and symptoms (Linehan & Wilks 2015).

Constructive emotional management therapies, which are based on DBT, are made up of a variety of skills that assist older persons in controlling their emotions, fostering better relationships, and enduring difficult circumstances without impulsivity. These interventions involve skills that should be incorporated and practiced into the daily lives of older individuals. They function similarly to muscles strengthen with use over

time. They instruct elderly people on what best skills are needed, when, and how to implement them. Thus further, constructive emotional management interventions could increase mental clarity, restore emotional dimensions, improve coping mechanisms, and lessen depressive symptoms as people age. The prevention or treatment of mental health issues as well as enhancing mental well-being and peace of mind in old age appear to be potential outcomes of constructive emotional management interventions with an emphasis on emotion-regulation. (Delhom et al., 2018).

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
80

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Alexandria, Egypt
        • Faculty of nursing
      • Alexandria, Egypt, 21523
        • Faculty of nursing

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:1. The ability to write and read. 2. Had a Mini Mental State Examination Scale (MMES) score of 24 or higher, indicating normal cognitive function.

3. Did not have depression, according to the Geriatric Depression Scale Short Form (GDS SF), which has a 0 to 4 score range.

4. Difficulties with emotional regulation: a score of 17 or higher on the Brief Version of the Difficulties in Emotion Regulation Scale: The DERS-16.

-

Exclusion Criteria: those who have cognitive impairment such as dementia

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: interventional group
senior citizens aged 60 and more were randomly assigned into two equal groups at and placed in the study group, which received the constructive emotional management interventions
Behavioral: constructive emotional management interventions
The Constructive emotional management interventions sessions were conducted in the activity rooms of the elderly clubs where the researchers met the participants. Participants completed a baseline evaluation of the outcome measures of the researched variables after being found to be eligible for the current study and indicating their willingness to participate willingly. After explaining the study's objectives to participants, the researchers themselves delivered the Constructive Emotional Management Interventions program, which had been vetted by experts in the field.
No Intervention: control group
the control group, which received the elderly clubs' regular services

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Time Frame
Mini-Mental State Examination Scale (MMES)
Time Frame: 3 month
3 month

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Time Frame
II) Geriatric Depression Scale- Short Form (GDS-SF)
Time Frame: 3 month
3 month

Other Outcome Measures

Other Outcome Measures

For clinical trials, a planned measurement described in the protocol that is used to determine the effect of an intervention/treatment on participants. For observational studies, a measurement or observation that is used to describe patterns of diseases or traits, or associations with exposures, risk factors, or treatment. Types of outcome measures include primary outcome measure and secondary outcome measure.
Outcome Measure
Time Frame
III) Brief Version of the Difficulties in Emotion Regulation Scale: The DERS-16
Time Frame: 3 month
3 month
IV) The Peace of Mind Scale: PoM
Time Frame: 3 month
3 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Alexandria University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
January 22, 2023

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
February 28, 2023

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
March 30, 2023

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
June 16, 2023

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 16, 2023

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
June 27, 2023

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
June 27, 2023

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 16, 2023

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
June 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 1512023

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings